Naïve CD8+ T cells seem to have a positive impact on HCC patient PFS, whereas Treg cells are likely to have a negative impact on HCC patient PFS, suggesting that these immune cell subsets may play a role in cancer progression and the response to treatment (Supplementary Figure S10). This evidence concerns the gene CD8A and hepatocellular carcinoma.